European Dividend Aristocrats: 40 Top International Dividend Stocks
Similar to their American counterparts, the S&P Europe 350 Dividend Aristocrats offer investors dividend hikes and blue-chip stability.
- (opens in new tab)
- (opens in new tab)
- (opens in new tab)
- Newsletter sign up Newsletter

U.S. equity markets aren't the only place where you can find income-producing royalty. Indeed, a quick look across the pond yields dozens, in the form of the European Dividend Aristocrats.
Admittedly, Europe's dividend stocks have posted subpar returns compared to their U.S. counterparts over the past decade. However, that could change this year, says Goldman Sachs strategist Guillaume Jaisson, who points to an unusually large yield gap between European stocks and bonds. At present, yields on eurozone bonds are miniscule; the choice between dividend-paying stocks and bonds seems an easy one.
In addition, Jaisson notes that higher-yielding dividend stocks are less sensitive to interest-rate hikes, and that their stable income payments look more attractive in both high-inflation and high-volatility environments, in which capital gains look less like a lock.

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The European Dividend Aristocrats in specific look enticing given the difference between dividend growth here and abroad. Jaisson says the Stoxx Europe 600 Index is expected to deliver 10% dividend growth this year, well beyond the 7% forecast for the S&P 500. (And beyond 2022, says CME Group, S&P 500 dividend growth is predicted at 1% excluding inflation.)
Another financial strategist recommending European dividend stocks is Morningstar senior equity analyst Michael Field. At present, the selection of high-yielding European dividend stocks is much larger than previous years, Field says. As a result, investors can build a high-yielding portfolio of European stocks without overly relying on traditional income sectors like financial and utilities.
"The European Central Bank is unlikely to be as aggressive in raising interest rates as the Federal Reserve, giving companies on the continent some headroom," Field adds.
Field warns that rising interest rates will likely penalize high-debt companies, however. So he recommends investors stick with high-quality European names that offer defensible moats and sustainable cash flow.
You can find many of these traits among the European Dividend Aristocrats – a small subset of the S&P Europe 350 Index.
The European Dividend Aristocrats
Like their U.S. counterparts, European Dividend Aristocrats are recognized for steady and growing dividends. Consistently rising dividends are not the norm in Europe so these stocks are a rare breed indeed.
Unlike the S&P 500 Dividend Aristocrats, which must deliver a minimum of 25 consecutive years of dividend growth, European Dividend Aristocrats need only show 10 years of stable or increasing dividends.
Another important difference is the frequency of payout. U.S. dividend stocks tend to pay dividends quarterly, whereas European payers tend to distribute income semiannually.
In other respects, the two groups of Aristocrats are similar. Companies that earn this elite status tend to be market leaders with multibillion-dollar valuations, consistent profits and mature business models.
The current crop of European Dividend Aristocrats offers several names that stand out for their rich yields and modest valuations. We'll look at a few highlights, then produce the full list.
- U.K. defense contractor BAE Systems (BAESY (opens in new tab), $36.63) benefits from current geopolitical tensions that are fueling interest in its next-generation Tempest fighter jets among European customers. Already well-known for its Typhoon fighter planes and work on the F-35 fighters, BAE System has hiked dividends 5% annually over the past three years. BAESY shares yield 3.6%, or more than two times the yield of the U.S. industrial sector. A forward price-to-earnings multiple of 14 represents a 15% discount to peers.
- French drug maker Sanofi (SNY (opens in new tab), $52.03) enjoys a wide moat thanks to its blockbuster drug Dupixent and is strengthening its best-in-class drug pipeline via acquisitions. Recent deals include Amunix, which adds 20 new drug candidates to the oncology pipeline, and Origimm, which is developing the healthcare industry's first vaccine candidate against acne vulgaris – a condition affecting millions of teenagers and adults. Sanofi grew dividends 4% in 2021 and 3% annually over the past five years. SNY yields 3.5%, which is roughly twice that of the healthcare sector, and its 12.3 forward P/E is almost 35% below the sector average.
- U.K. pension specialist Legal & General (LGGNY (opens in new tab), $15.21) has tapped into Europe's aging population to generate 11% annual EPS and dividend growth over the past decade. The company is one of Europe's largest asset managers, thanks to its mature life insurance, pension and annuities segments, and is making big investments in housing and infrastructure that should pay off handsomely in the future. LGGNY shares yield an eye-popping 8.1% and are priced at a lowly 7 times earnings estimates – a roughly 35% discount to financial peers.
- London-based consumer goods giant Unilever (UL (opens in new tab), $46.17) boasts a powerful brand portfolio and the advantages of significant scale and sustainable cash flow. Its brands – which include Dove soap, Knorr sauces and seasonings, Lipton tea and Hellmann's mayonnaise – are household names. Unilever grew dividends by 5% last year and at a 7% annual clip over the past five years. Yield is generous at 4.2%, and UL shares trade at 18 times profit estimates – a slight discount to the consumer staples sector but a 10% discount to its own historical valuation.
There are a total of 40 names on the 2022 list of European Dividend Aristocrats. Member stocks and their recent dividend yield are provided in the table below:
Lisa currently serves as an equity research analyst for Singular Research covering small-cap healthcare, medical device and broadcast media stocks.
-
-
Long-Term Care Planning vs. Taxes: Finding a Healthy Balance
Many families discover that trying to mitigate the cost of long-term care can conflict with another common retirement concern — reducing taxes for retirees and their heirs.
By John M. Graves, Esq., IAR, Agent • Published
-
For a Concentrated Stock Position, Ask Your Adviser This
There can be advantages to having a lot of stock in one company, but ‘de-risking’ can help avoid some significant disadvantages.
By Robert Gorman • Published
-
Stock Market Today: Stocks Fall After First Republic Bank Suspends Dividend
The embattled lender's dividend cut was just the latest sign of instability in the banking industry.
By Karee Venema • Published
-
Stock Market Today: Stocks Rally on Credit Suisse, First Republic Bank Rescue News
Reports that major U.S. banks would step in to help First Republic Bank helped stocks swing higher Thursday.
By Karee Venema • Published
-
If You'd Put $1,000 Into Netflix Stock 20 Years Ago, Here's What You'd Have Today
Netflix Netflix stock is down almost 60% from its all-time closing high, but it's still a big-time market beater.
By Dan Burrows • Published
-
Stock Market Today: Stocks Struggle on Credit Suisse, First Republic Bank Concerns
Chaos in the financial sector stole the spotlight from this morning's inflation and retail sales updates.
By Karee Venema • Published
-
Stock Market Today: Markets Rise as Bank Stocks Bounce
Investors also focused on the February CPI report, which gave a mixed picture on inflation.
By Karee Venema • Published
-
Stock Market Today: Nasdaq Gains as Treasury Yields Collapse
The tech-heavy index swung higher Monday as investors sought out safety in government bonds.
By Karee Venema • Published
-
Stock Market Today: Silicon Valley Bank Failure Sinks Stocks
The largest bank failure since the 2008 financial crisis stole the spotlight from the February jobs report.
By Karee Venema • Published
-
Stock Market Today: Stocks Sink Ahead of February Jobs Report
The major benchmarks finished solidly lower Thursday as bank stocks sold off.
By Karee Venema • Published